Synapse - Dmitriy Zamarin

Results (201)

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

Journal Article

Rios-Doria, E.; Momeni-Boroujeni, A.; Friedman, C. F.; Selenica, P.; Zhou, Q.; Wu, M.; Marra, A.; Leitao, M. M. Jr; Iasonos, A.; Alektiar, K. M.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype

Journal Article

Dessources, K.; Ferrando, L.; Zhou, Q. C.; Iasonos, A.; Abu-Rustum, N. R.; Reis-Filho, J. S.; Riaz, N.; Zamarin, D.; Weigelt, B.
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Phase I study of a multivalent WT1 peptide vaccine (galinpepimut-S) in combination with nivolumab in patients with WT1-expressing ovarian cancer in second or third remission

Journal Article

Manning-Geist, B. L.; Gnjatic, S.; Aghajanian, C.; Konner, J.; Kim, S. H.; Sarasohn, D.; Soldan, K.; Tew, W. P.; Sarlis, N. J.; Zamarin, D.; more...
Cancers (2023)

Fulltext@MSK | Save

Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus

Editorial

Henson, C. E.; Morton, D. J.; Mayadev, J. S.; Wong, S. J.; Zamarin, D.
Cancer (2023)

Fulltext@MSK | Save

High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer

Journal Article

Ashley, C. W.; Selenica, P.; Patel, J.; Wu, M.; Nincevic, J.; Lakhman, Y.; Zhou, Q.; Shah, R. H.; Berger, M. F.; Da Cruz Paula, A.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Journal Article

Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

State of the biomarker dcience in ovarian cancer: A National Cancer Institute Clinical Trials Planning Meeting Report

Journal Article

Ethier, J. L.; Fuh, K. C.; Arend, R.; Konecny, G. E.; Konstantinopoulos, P. A.; Odunsi, K.; Swisher, E. M.; Kohn, E. C.; Zamarin, D.
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Germline SMARCA4 deletion as a driver of uterine cancer: An atypical presentation

Journal Article

Navitski, A.; Al-Rawi, D. H.; Makker, V.; Weigelt, B.; Zamarin, D.; Liu, Y.; Arnold, A. G.; Chui, M. H.; Mandelker, D. L.; Walsh, M.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

MEDI1191 (IL-12 MRNA) induces peripheral and intratumoral immunostimulatory effect in patients with cutaneous or subcutaneous (c/sc) lesions

Meeting Abstract

Abadier, M.; Jennings, E.; Eyles, J.; Martin, P.; Pilataxi, F.; Wu, Y.; Chen, X.; Azaro, A.; Ridgway, B.; Phillips, M.; more...
Journal for ImmunoTherapy of Cancer (2022)

Fulltext@MSK | Save

A phase 1a/1b study of STK-012, an α/β IL-2 receptor selective partial agonist as monotherapy and in combination with pembrolizumab in advanced solid tumors (NCT05098132)

Meeting Abstract

Spigel, D.; Spira, A.; Zamarin, D.; McDermott, D. F.; Luke, J.; Heymach, J. V.; Previs, R.; Sullivan, R.; Gandhi, L.; Azrilevich, A.; more...
Cancer Research (2022)

Fulltext@MSK | Save